What You Ought to Know:
– Certara, a world chief in model-informed drug improvement, immediately introduced an expanded collaboration with Merck, referred to as MSD exterior of america and Canada.
– The strategic settlement will see Merck enhance its use of the Certara Pinnacle 21 software program platform to incorporate a metadata repository and information requirements workflow administration. This builds upon Merck’s present expertise collaboration with Certara aimed toward aiding regulatory submissions.
Addressing Knowledge Standardization Challenges in Trendy Medical Trials
The method of reworking uncooked information into validated, analysis-ready datasets has grow to be more and more complicated in fashionable drug improvement. This problem is amplified by the sheer quantity of information collected; Part III medical trials now common 3.6 million information factors, representing a threefold enhance during the last decade.
The Certara Pinnacle 21 platform is particularly designed to unravel these information standardization challenges at scale. By increasing its use of this platform, Merck goals to additional streamline its information administration processes.
“We’re happy to strengthen our ongoing collaboration with Merck to help with information requirements administration and to broaden the worth of the Pinnacle 21 platform,” stated William F. Feehery, Chief Government Officer of Certara. He emphasised the alignment between the 2 corporations, stating, “Merck is a premier research-intensive firm, and our groups are well-aligned within the aim of delivering high-quality analysis information quicker to assist save and enhance lives all over the world”.
